Results
|
|
1.
|
Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile. MedStar authors:
Year: 2020
Citation: - Chest. 157(1):151-161, 2020 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Baumgartner WA, Crawford TC, De Marco T, Fraser CD 3rd, Gilotra NA, Houston BA, Leary PJ, Magruder JT, Maron BA, Masri SC, Ramu B, Russell SD, Sharma K, Sheikh F, Suarez-Pierre A, Tedford RJ, Whitman GJ, Zehr KJ
|
|
|
2.
|
Non-infectious pulmonary disorders in HIV. MedStar authors:
- Shorr, Andrew F
- Thao, Choua
- Woods, Christian J
Year: 2017
Citation: - Expert Review of Respiratory Medicine. 11(3):209-220, 2017 Mar
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Shorr AF, Thao C, Woods C
|
|
|
3.
|
Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. MedStar authors:
- Barbash, Israel M
- Ben-Dor, Itsik
- Escarcega, Ricardo O
- Goldstein, Steven A
- Minha, Sa'ar
- Okubagzi, Petros
- Pichard, Augusto D
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
- Wang, Zuyue
Year: 2015
Citation: - American Journal of Cardiology. 115(10):1435-42, 2015 May 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Barbash IM, Ben-Dor I, Escarcega RO, Goldstein SA, Minha S, Okubagzi P, Pichard AD, Satler LF, Torguson R, Waksman R, Wang Z
|
|
|
4.
|
Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial. MedStar authors:
- Asch, Federico M
- Medvedofsky, Diego
- Weissman, Neil J
Year: 2020
Citation: - Journal of the American College of Cardiology. 76(22):2595-2606, 2020 12 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Abraham WT, Asch FM, Ben-Yehuda O, Chen S, Grayburn P, Hahn RT, Kapadia S, Kar S, Lim S, Lindenfeld J, Liu M, Mack MJ, Medvedofsky D, Puri R, Redfors B, Sannino A, Shahim B, Stone GW, Weissman NJ
|
|
|
5.
|
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors:
Year: 2018
Citation: - New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD
|
